{
    "project_id": "170994",
    "broad_study_type": "other",
    "narrow_study_type": "drug_development",
    "trial_phase": "preclinical",
    "observational_timeframe": "N/A",
    "justification": "The aim of this project is to study the role of inflammation in ischemic brain injury and to develop novel therapeutic strategies by modulating inflammatory response to promote brain repair and recovery.",
    "data_type": "canadian",
    "ipd_used": "individual",
    "novelty_statement": "The in vivo results obtained in our preliminary studies suggest that inflammatory response after stroke lasts much longer than initially thought (several months after stroke) and therefore may represent a good therapeutic target to stimulate brain recovery.",
    "replication_study": "no",
    "target_population_size": "N/A",
    "age_range": "unclear",
    "gender_focus": "unclear",
    "vulnerable_populations": "no",
    "rare_disease": "no",
    "population_description": "transgenic mouse models",
    "intervention_category": "drug",
    "intervention_name": "pro- and anti-inflammatory treatments",
    "control_type": "experimental_control",
    "dose_response": "unclear",
    "combination_therapy": "no",
    "personalized_medicine": "no",
    "primary_outcome": "brain repair and functional recovery after stroke",
    "primary_outcome_type": "functional",
    "safety_focus": "no",
    "quality_of_life": "no",
    "biomarker_endpoints": "yes",
    "time_to_event": "no",
    "composite_endpoint": "no",
    "ai_machine_learning": "no",
    "digital_health": "yes",
    "telemedicine": "no",
    "wearable_technology": "no",
    "big_data_analytics": "no",
    "blockchain": "no",
    "cost_effectiveness": "no",
    "budget_impact": "no",
    "health_technology_assessment": "no",
    "resource_utilization": "no",
    "productivity_outcomes": "no",
    "implementation_science": "no",
    "policy_evaluation": "no",
    "health_system_integration": "no",
    "scalability_assessment": "no",
    "barrier_identification": "no",
    "adaptive_design": "no",
    "bayesian_methods": "no",
    "machine_learning_analysis": "no",
    "novel_biostatistics": "no",
    "patient_reported_outcomes": "no",
    "real_world_evidence": "no",
    "industry_partnership": "no",
    "patient_engagement": "no",
    "community_based": "no",
    "indigenous_collaboration": "no",
    "international_collaboration": "no",
    "international_network": "no",
    "regulatory_pathway": "yes",
    "ethics_focus": "no",
    "consent_innovation": "no",
    "data_sharing": "no",
    "therapeutic_area": "neurology",
    "disease_stage": "acute",
    "comorbidity_focus": "no",
    "pandemic_related": "no",
    "environmental_health": "no",
    "social_determinants": "no",
    "health_equity": "no",
    "climate_health": "no",
    "urban_rural": "unclear",
    "biobank_use": "no",
    "registry_linkage": "no",
    "cohort_establishment": "no",
    "platform_trial": "no",
    "study_duration": "long_term",
    "multicenter": "no",
    "healthcare_setting": "laboratory",
    "disease_area": "stroke",
    "methodology_innovation": "using transgenic mouse models and in vivo bioluminescence/biophotonic imaging to study inflammation and brain repair after stroke",
    "knowledge_translation_focus": "yes",
    "equity_considerations": "no"
} 